N/A N=78 Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
Diabetes Mellitus, Type II
Primary: Percent Change in Plasma Triglycerides — -2.0; 16.0; -5.0; -5.0 percent change
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=52 Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
Type 1 Diabetes Mellitus
Primary: Hemoglobin A1c — 7.988; 8.025 A1c percentage
Phase 2 N=114 New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Diabetes Mellitus, Type 1
Primary: Mean Stimulated C-peptide Area Under the Curve — 0.28; 0.27; 0.25 pmol/ml — p=0.47
N/A N=34 Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Diabetes Remission Rate — 3; 6 Participants — p=<0.0001
N/A N=23 Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
Type 2 Diabetes
Primary: Peak Oxygen Consumption (VO2 Peak) — 16.6; 16.1 milliliters per kilogram per minute
N/A N=57 Effect of Diabetes Mellitus on Cholesterol Metabolism
Type 1 Diabetes Mellitus · Type 2 Diabetes Mellitus · Hypercholesterolemia
Primary: Changes in LDL Cholesterol — -0.83; -1.47; -0.93; -0.32 mmol/L
Phase 3 N=560 Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
Primary: Rate of Type 1 Diabetes Per Year Among Individuals in the Primary Stratum When Treated With Oral Inulin Versus Placebo — 0.088; 0.102 Proportion with diabetes/year
N/A N=259 Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)
Severe Hypoglycemia
Primary: Self-reported Severe Hypoglycemia — 99; 99; 19; 13 Participants — p=0.27
Phase 3 N=166 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Diabetes Mellitus, Type 2 · Hypertension
Primary: Change From Baseline in Glycated Haemoglobin (HbA1c) (%) at 24 Weeks — 0.07; -0.71 percentage of glycated haemoglobin — p=0.0002
N/A N=79 Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
Primary: Self-Care Activities: Healthy Eating — 4.23; 4.67; 4.61; 4.60 days/week (min: 0 days; Max: 7 days)
Phase 3 N=28 Adjunctive Metformin Therapy in Double Diabetes
Diabetes Mellitus
Primary: Baseline Adjusted Hemoglobin A1c Over Time — 9.46; 9.85 percentage of HbA1c — p=0.903
N/A N=60 Arterial Stiffness in Type I Diabetes Mellitus
Arterial Stiffness in Youth With Type 1 Diabetes
Primary: Determine the Difference Between Acute Effect of a Mixed Meal on Radial Artery Stiffness in Subjects With Type I Diabetes Mellitus Who do and Who do Not Take an…
N/A N=10 Salsalate for Insulin Resistance in Schizophrenia
Schizophrenia · Insulin Resistance
Primary: Side Effects of Salsalate — 3 participants
N/A N=16 Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.
Diabetes Mellitus
Primary: Percentage of Time Spent in Hyperglycemia > 180 mg/dL — 35.47; 35.25 percentage of time spent > 180mg/dL
N/A N=96,759 Impact of Medicaid Health Home on Patients With Diabetes in New York City
Type 2 Diabetes Mellitus
Primary: Number of Enrollees With Diabetes-related Preventable Hospitalizations — 48; 109; 48; 90 Participants